科研动态PubMed 摘要

NCCN指南®见解:肝细胞癌,2026年第2版。

PubMed 学科轮询 · 2026-01-01

完整摘要 · 中文译文

肝细胞癌(HCC)是最常见的肝脏原发性恶性肿瘤。NCCN肝细胞癌指南为HCC患者的全程管理提供推荐意见,包括筛查、评估、治疗和监测。多学科专家小组至少每年召开一次会议,根据新的数据和最新研究进展讨论NCCN指南的更新。本期指南解读重点介绍近期部分更新内容。

完整摘要 · 英文原文

Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver. The NCCN Guidelines for HCC provide recommendations for the comprehensive care of patients with HCC, including screening, evaluation, treatment, and surveillance. The multidisciplinary panel of experts meets at least once a year to discuss updates to the NCCN Guidelines based on new and emerging data. These Guidelines Insights focus on some of the recent updates.

English
NCCN Guidelines® Insights: Hepatocellular Carcinoma, Version 2.2026.
内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界